Prebiotics
| Code | Product Name | Standardization |
|---|---|---|
| 0565 |
Fenugreek Fibers Trigonella foenum-graecum FenuFibers® |
50% Total Dietary Fiber 15% Protein 2.5% Steroidal Saponins |
| 0570 |
Fenugreek Extract Trigonella foenum-graecum Fenumannan® |
60% Galactomannan |
| 1944 |
Turmeric Starch (1) New Curcuma longa Starmeric® |
40% Total Starch 20% Resistant Starch |
Probiotics
| Code | Product Name | Standardization |
|---|---|---|
| 1205 |
Bacillus coagulans Weizmannia coagulans (MTCC 5856) (1,2,3) (Bacillus coagulans) LactoSpore® GRAS AFFIRMED |
6 Billion Organisms/g |
| 1200 |
Bacillus coagulans Weizmannia coagulans (MTCC 5856) (1,2,3) (Bacillus coagulans) LactoSpore® GRAS AFFIRMED |
15 Billion Organisms/g |
| 1201 |
Bacillus coagulans Weizmannia coagulans (MTCC 5856) (1,2,3) (Bacillus coagulans) LactoSpore® GRAS AFFIRMED |
100 Billion Organisms/g |
Postbiotics
| Code | Product Name | Standardization |
|---|---|---|
| 0909 | ImmunoSpore™ New (Bacillus coagulans MTCC 5856) |
15 Billion spores/g count before heat inactivation 1,000 spores/g count after heat inactivation |
Synbiotics
| Code | Product Name | Standardization |
|---|---|---|
| 1206 | LactoWise® | 15 Billion Organisms/g 45% Galactomannan 5% Protein |
| 1101 | LactoCran® (3) New | 2 Billion Organisms/g Organic Cranberry Seed/Juice |
PATENTS
(1) LactoSpore® + Turmeric Starch (Starmeric® )
US 10,323,227: Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof
(2) LactoSpore®
US 10,668,115: Stable probiotic compositions containing Bacillus coagulans MTCC 5856 and method of detection thereof
US 10,609,935: Beverage compositions containing Bacillus coagulans MTCC 5856
US 9,579,352: Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans
US 10,166,261; AU2016413572; CA3023818; ZL2019/00501: Bacillus coagulans MTCC 5856 for the management of major depressive disorder
US 10,260,112; CA2999517; EP3356545; MY-185340-A: Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856
EA037312; EP3240553; JP6629875; KR10-2157043;MY-182658-A; ZL 201680008035.7: Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856
US 10,806,760: Compositions and methods for reducing flatulence
US 10,293,008; AU2015308650; EA034017; EP3185877;HK1233174; IDP000066793; JP6630723; KR10-2089566;MX376004; MY-174855-A; SG11201700006U;ZL201580042813.X: Process for enhancing the viable counts of lactic acid bacteria and useful composition thereof
US 10,792,295; JP6839329: Composition for management of Helicobacter pylori infection
RU2745755: Anti-pollution compositions containing Bacillus coagulans
(3) LactoCran®
US 9,717,766: Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof
†Disclaimer
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
